TP53 and neoplasm: Overexpression and/or mutations in the Per2 gene correlate with enhanced tumor growth in breast cancer, colon cancer, and lymphoma, along with altered expression of TP53 and the oncogenes BCLxl, BCL-2, cyclinB1, cyclin D, cyclin E, and c-myc [11–16].